Gelteq revenue was $0.00 for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2024) ending on Jun 30, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Jun 30, 2024, GELS annual revenue was $0.0, with -100% growth year-over-year.
GELS past revenue growth
How has GELS's revenue growth performed historically?
Gelteq (NASDAQ: GELS) reported Q2 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Gelteq's revenue was $0.00.
What was Gelteq's revenue in 2024?
Gelteq's annual revenue for the twelve months ending Jun 30, 2024 was $0.00, a 100% decrease year over year.
How much does Gelteq make in a day?
Based on Gelteq annual revenue for the past four years, GELS makes an average of $107.89 per day.
What was Gelteq's annual revenue growth in the past year?
As of Q2 2025, Gelteq's revenue has grown -100% year over year. This is 110.09 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.09%. Gelteq's revenue in the past year totaled $0.00.
How much does Gelteq make in a year?
Gelteq's revenue by year for the past four years is:
Gelteq's revenue for the twelve months ending Jun 30, 2024 was $0.00, a 100% decrease year over year.
Gelteq's annual revenue for Jun 30, 2023 was $55.06 thousand, a 46.26% decrease from 2022.
Gelteq's annual revenue for 2022 was $102.46 thousand, a Infinity% increase from 2021.
Gelteq's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.